Sinco Pharmaceutical Holdings Ltd (HKSE:06833) Share Price

Company Profile

Business description
Sinco Pharmaceutical Holdings Ltd is an investment holding company that deals in marketing, promotion, and channel management of improved human plasma-based pharmaceuticals, antibiotics, and other pharmaceuticals. The company operates in three business segments, namely biologics, medical aesthetic products, and biopharmaceutical cold chain and supply chain services. The biologics business provides marketing, promotion, and channel management services, while the medical aesthetic products business focuses on research and development, production, and sales of aesthetic medicine in China. The biopharmaceutical cold chain and supply chain services concentrate on the construction of cold chain facilities for biopharmaceutical products and establishing the supply chain service platform.
Contact
No. 1700, North Section of Tianfu Avenue
E5-1805, Global Centre
High-Tech Zone, Chengdu
Sichuan Province
Chengdu
CHN
T: +86 2862912988
https://www.sinco-pharm.com
Sector
Healthcare
Stock type
Defensive
Industry
Medical Distribution
Fiscal Year End
31 December 2025
Employees
291

Recommended

We were wrong when we thought last quarter would be hard to top.

Dan Romanoff, CPA | 31 July 2025

These undervalued stocks with wide and narrow moats have increased their dividends for 25 consecutive years or more.

Susan Dziubinski | 30 July 2025

We raise our Fair Value estimates but still think that current share prices rely on overly optimistic expectations.

Shaun Ler | 30 July 2025

Index	Last price	Change	% Change
All Ordinaries	8,999.00	16.40	-0.18%
CAC 40	7,838.17	23.79	-0.30%
DAX 40	24,229.68	32.54	-0.13%
Dow JONES (US)	44,461.28	171.71	-0.38%
FTSE 100	9,174.09	37.15	0.41%
HKSE	24,773.33	403.60	-1.60%
NASDAQ	21,129.67	31.38	0.15%
Nikkei 225	41,069.82	415.12	1.02%
NZX 50 Index	12,823.74	32.23	-0.25%
S&P 500	6,362.90	0.00	0.00%
S&P/ASX 200	8,742.80	13.60	-0.16%
SSE Composite Index	3,573.21	42.51	-1.18%